Cardiac ATP-sensitive K+ (K-ATP) channels (SUR2A plus Kir6.2) couple t
he metabolic state of the myocyte to its electrical activity via a mec
hanism that is not well understood. Recent pharmacological evidence su
ggests that K-ATP channels may mediate ischemic preconditioning. Howev
er, there is no potent pharmaceutical agent that specifically blocks t
he sarcolemmal K-ATP channel without significant effects on other cell
ular proteins. As a molecular tool, the GFG sequence in the H5 loop of
the murine Kir6.2 channel was mutated to AFA. This mutated channel su
bunit (6.2AFA) suppressed wildtype Kir6.2 (6.2WT) channel current in a
dominant-negative manner: when co-expressed with SUR2A and 6.2WT, who
le-cell K-ATP current recorded from HEK cells was greatly attenuated.
The 6.2AFA subunit also co-assembled with endogenous subunits in both
smooth-muscle-derived A10 cells and rat neonatal ventricular myocytes,
resulting in a significant reduction of current compared with that re
corded from non-transfected or mock-transfected cells (<15% of control
for both cell types). This study shows that mutation of GFG-->AFA in
the putative pore-forming region of Kir6.2 acts in a dominant-negative
manner to suppress current in heterologous systems and in native cell
s.